Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Influence of Rhythm and Interpersonal Relationship on Gait Parameters in Children With Autism Spectrum Disorder

1 de outubro de 2026 atualizado por: Estrada Barranco, Universidad Europea de Madrid

Influence of Rhythm and Interpersonal Relationship on Gait Parameters in Children With Autism Spectrum Disorder: A Controlled Intervention Study

Autism Spectrum Disorder (ASD) is associated with differences in social communication, motor coordination, interpersonal synchronization, and gait. This randomized crossover study examined the influence of walking pace and social familiarity on gait parameters in 30 children aged 4-6 years with ASD. Participants completed 10-metre walking trials at three pacing conditions (100, 120, and 140 beats per minute) while walking alongside either their mother or an unfamiliar researcher. The order of the two social conditions was randomized, and all participants completed both conditions. Spatiotemporal and lower-limb kinematic gait parameters were assessed from video recordings.

Visão geral do estudo

Descrição detalhada

Study Design:

This randomized crossover interventional study assessed the influence of walking pace and social familiarity on gait parameters in children diagnosed with Autism Spectrum Disorder (ASD). The study included 30 children aged 4-6 years with ASD level I or II who were able to walk independently without assistive devices. Participants were recruited from Fundación AMÁS, an early intervention centre.

Participants were randomly assigned to one of two sequences. Fifteen participants completed the mother condition first, followed by the unfamiliar-researcher condition, and fifteen completed the unfamiliar-researcher condition first, followed by the mother condition. All participants therefore completed both social walking conditions. Randomization applied to the order of the social conditions.

Walking Procedure:

Participants completed walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, the child walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants.

The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. Each child completed three repetitions of a 10-metre walk in each condition.

Video recordings were obtained from a lateral view under standardized recording conditions. Only the central 2 metres of the final repetition were analysed to exclude the acceleration and deceleration phases. Gait parameters were assessed from the recordings using Kinovea® software.

Outcome Measures:

The assessed outcomes were gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles at eight predefined events and phases of the gait cycle: initial contact, loading response, mid-stance, terminal stance, pre-swing, initial swing, mid-swing, and terminal swing.

Study Population:

Eligible participants were children aged 4-6 years with a clinical diagnosis of ASD level I or II who attended regular therapy sessions at Fundación AMÁS and were able to walk independently. Children with associated syndromes or recent interventions affecting the lower limbs were excluded.

Tipo de estudo

Intervencional

Inscrição (Real)

30

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Madrid
      • Madrid, Madrid, Espanha, 28670
        • Universidad Europea de Madrid

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

4 anos a 6 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Children aged 4 to 6 years.
  • Clinical diagnosis of Autism Spectrum Disorder (ASD) (Level I or II).
  • Ability to walk independently without the use of assistive devices.
  • Parents or legal guardians provide informed consent for participation.

Exclusion Criteria:

  • Presence of other syndromes or developmental disorders.
  • History of recent surgical interventions or procedures involving the lower limbs.
  • Significant neurological or orthopedic conditions that may affect gait.
  • Any contraindications for participation in physical activities as determined by the child's healthcare provider.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição cruzada
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Mother-first sequence

Fifteen participants first completed the walking trials alongside their mother and subsequently crossed over to complete the trials alongside the unfamiliar researcher. Participants performed the walking task under the three pacing conditions (100, 120, and 140 bpm).

Participants completed 10-metre walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, participants walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants. The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. All participants completed both social conditions, with the order of the mother and unfamiliar-researcher conditions determined by random allocation. Gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles were assessed from video recordings using Kinovea® software.

Experimental: Unfamiliar-researcher-first sequence

Fifteen participants first completed the walking trials alongside the unfamiliar researcher and subsequently crossed over to complete the trials alongside their mother. Participants performed the walking task under the three pacing conditions (100, 120, and 140 bpm).

Participants completed 10-metre walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, participants walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants. The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. All participants completed both social conditions, with the order of the mother and unfamiliar-researcher conditions determined by random allocation. Gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles were assessed from video recordings using Kinovea® software.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Cadence
Prazo: During each walking condition within a single assessment session.

The number of steps taken per minute.

During each walking condition within a single assessment session.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Step Length
Prazo: During each walking condition within a single assessment session.

The distance covered in a single step, measured in meters

During each walking condition within a single assessment session.
Step Time: The duration of each step, measured in seconds
Prazo: During each walking condition within a single assessment session.

The duration of each step, measured in seconds

During each walking condition within a single assessment session.
Velocity:
Prazo: During each walking condition within a single assessment session.

The speed of walking, measured in meters per second.

During each walking condition within a single assessment session.
Joint Amplitudes
Prazo: During each walking condition within a single assessment session.

The angles at which the hip, knee, and ankle joints move during each phase of the gait cycle, assessed in degrees

During each walking condition within a single assessment session.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de fevereiro de 2024

Conclusão Primária (Real)

31 de maio de 2024

Conclusão do estudo (Real)

31 de maio de 2024

Datas de inscrição no estudo

Enviado pela primeira vez

4 de outubro de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

23 de outubro de 2024

Primeira postagem (Real)

26 de outubro de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

1 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Data Sensitivity: Given that the study focuses on a vulnerable population (children with Autism Spectrum Disorder), there are heightened concerns regarding the misuse or misinterpretation of the data.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever